Viatris (VTRS) Market Capitalization (2019 - 2026)
Viatris (VTRS) posted Market Capitalization of $18.2 billion for Q2 2026, up 15.93% on a QoQ basis from $15.7 billion in Q1 2026, and up 75.19% year-over-year from $10.4 billion in Q2 2025.
Analysis
Viatris (VTRS) Market Capitalization (2019 - 2026) Analysis & Trends
Viatris has reported Market Capitalization for 8 years, with the latest figure at $18.2 billion in Q2 2026.
- On a quarterly basis, Market Capitalization rose 75.19% year-over-year to $18.2 billion in Q2 2026; TTM through Jun 2026 was $18.2 billion, a 75.19% increase from a year earlier, with the FY2025 full-year figure at $14.3 billion, down 3.54% from the prior year.
- Market Capitalization was $18.2 billion for Q2 2026 at Viatris, up from $15.7 billion in the prior quarter.
- The five-year high for Market Capitalization was $18.2 billion in Q2 2026, with the low at $10.2 billion in Q1 2025.
- Average Market Capitalization over 5 years is $13.0 billion, with a median of $12.8 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: Market Capitalization slumped 36.95% in 2022, then soared 75.19% in 2026.
- Over 5 years, Market Capitalization stood at $13.3 billion in 2022, then declined by 3.45% to $12.9 billion in 2023, then increased by 15.55% to $14.9 billion in 2024, then fell by 3.54% to $14.3 billion in 2025, then increased by 27.24% to $18.2 billion in 2026.
- The last three Market Capitalization figures came in at $18.2 billion (Q2 2026), $15.7 billion (Q1 2026), and $14.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.24 Bn |
| Mar 31, 2026 | 15.73 Bn |
| Dec 31, 2025 | 14.33 Bn |
| Sep 30, 2025 | 11.40 Bn |
| Jun 30, 2025 | 10.41 Bn |
| Mar 31, 2025 | 10.22 Bn |
| Dec 31, 2024 | 14.86 Bn |
| Sep 30, 2024 | 13.86 Bn |
| Jun 30, 2024 | 12.69 Bn |
| Mar 31, 2024 | 14.22 Bn |
| Dec 31, 2023 | 12.86 Bn |
| Sep 30, 2023 | 11.83 Bn |
| Jun 30, 2023 | 11.97 Bn |
| Mar 31, 2023 | 11.53 Bn |
| Dec 31, 2022 | 13.32 Bn |
| Sep 30, 2022 | 10.33 Bn |
| Jun 30, 2022 | 12.70 Bn |
| Mar 31, 2022 | 13.19 Bn |
| Dec 31, 2021 | 16.37 Bn |
| Sep 30, 2021 | 16.39 Bn |